PROGRESS: Management of Moderate Aortic Stenosis by Clinical Surveillance or TAVR

Recruiting now · Not applicable

Conditions studied: Aortic Stenosis, Calcific, Aortic Valve Stenosis

In brief

This study objective is to establish the safety and effectiveness of the Edwards SAPIEN 3 / SAPIEN 3 Ultra / SAPIEN 3 Ultra RESILIA Transcatheter Heart Valve systems in subjects with moderate, calcific aortic stenosis. Following completion of enrollment, subjects will be eligible for enrollment in the continued access phase of the trial.

Key facts

Study ID
NCT04889872
Run by
Edwards Lifesciences
People needed
2250
Starts
2021-10-12
Expected to finish
2037-06-01
Last updated by the study team
2025-12-17

Who can join

Age: 65 and older. Sex: any. Healthy volunteers: not accepted.

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.